This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Issues Reconsidered

E. Russell Alexander, MD

JAMA. 1984;251(20):2710-2712.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

It is difficult to look back at an important scientific contribution and to assess the full significance of the work. It must be evaluated in relation to the time in which it was written. What were its roots? What was the notable contribution of this work? Furthermore, where did it lead us? Only with that precious gift of knowing what really happened can we now look back and assess the broader significance of the contribution. Thus, we can examine the important article, "Considerations in the Preparation and Use of Poliomyelitis Vaccine," by Jonas Salk, published in THE JOURNAL in August 1955.¹

First Polio Vaccine

In that year, there was an urgent problem, and this article represented one important response. Salk had been the first to take advantage of the basic contribution of Enders et al² in the propagation of poliovirus in non-neural tissue cultures and produced a formalininactivated . . . [Full Text PDF of this Article]

Author Affiliations
From the Operational Research Branch, Division of Sexually Transmitted Diseases, Center for Prevention Services, Centers for Disease Control, Atlanta.

Footnotes
Reprint requests to Technical Information Service, Center for Prevention Services, Centers for Disease Control, Atlanta, GA 30333 (Dr Alexander).

A commentary on Salk JE: Considerations in the preparation and use of poliomyelitis virus vaccine. JAMA 1955;158:1239-1248.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?